Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CUDC-907 enhances TRAIL-induced apoptosis through upregulation of DR5 in breast cancer cells
Zhaojun Li, Ya‐Jun Hou, Gangping Hao, et al.
Journal of Cell Communication and Signaling (2020) Vol. 14, Iss. 4, pp. 377-387
Open Access | Times Cited: 21

Showing 21 citing articles:

Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted therapies
Minru Liao, Rui Qin, Wei Huang, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 95
Anticancer properties of histone deacetylase inhibitors – what is their potential?
Kajetan Kiełbowski, Agata Szwedkowicz, Paulina Plewa, et al.
Expert Review of Anticancer Therapy (2025), pp. 1-16
Closed Access | Times Cited: 1
Dual inhibitors of histone deacetylases and other cancer-related targets: A pharmacological perspective
Yuan Gao, Hang Zhang, Frédéric Lirussi, et al.
Biochemical Pharmacology (2020) Vol. 182, pp. 114224-114224
Open Access | Times Cited: 60
Combating TKI resistance in CML by inhibiting the PI3K/Akt/mTOR pathway in combination with TKIs: a review
Priyanka Singh, Veerandra Kumar, Sonu Gupta, et al.
Medical Oncology (2021) Vol. 38, Iss. 1
Closed Access | Times Cited: 49
A review of progress in o-aminobenzamide-based HDAC inhibitors with dual targeting capabilities for cancer therapy
Weixin Zhang, Jiao Huang, Xin-Yi Tian, et al.
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115673-115673
Closed Access | Times Cited: 22
Licochalcone D exhibits cytotoxicity in breast cancer cells and enhances tumor necrosis factor‐related apoptosis‐inducing ligand‐induced apoptosis through upregulation of death receptor 5
Yunyun Zhang, Linlin Wang, Chuxuan Dong, et al.
Journal of Biochemical and Molecular Toxicology (2024) Vol. 38, Iss. 7
Closed Access | Times Cited: 6
The role of protein acetylation in carcinogenesis and targeted drug discovery
Jingru Yang, Cong Song, Xianquan Zhan
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 28
Dual Targeting of PI3K and HDAC by CUDC-907 Inhibits Pediatric Neuroblastoma Growth
Rameswari Chilamakuri, Saurabh Agarwal
Cancers (2022) Vol. 14, Iss. 4, pp. 1067-1067
Open Access | Times Cited: 24
Anti-tumor effects of dual PI3K-HDAC inhibitor CUDC-907 on activation of ROS-IRE1α-JNK-mediated cytotoxic autophagy in esophageal cancer
Jian Zheng, Yichao Han, Wentian Zhang, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 13
Licochalcone B induces DNA damage, cell cycle arrest, apoptosis, and enhances TRAIL sensitivity in hepatocellular carcinoma cells
Yunyun Zhang, Panpan Feng, Hongfei Wang, et al.
Chemico-Biological Interactions (2022) Vol. 365, pp. 110076-110076
Closed Access | Times Cited: 12
Scutebarbatine A induces cytotoxicity in hepatocellular carcinoma via activation of the MAPK and ER stress signaling pathways
Panpan Feng, You‐kun Qi, Na Li, et al.
Journal of Biochemical and Molecular Toxicology (2021) Vol. 35, Iss. 5
Closed Access | Times Cited: 15
Design and synthesis of highly TRAIL expression HDAC inhibitors based on ONC201 to promote apoptosis of colorectal cancer
Cui Hao, Zan Hu, Yang Kang, et al.
European Journal of Medicinal Chemistry (2022) Vol. 238, pp. 114484-114484
Closed Access | Times Cited: 9
CUDC‑907 suppresses epithelial‑mesenchymal transition, migration and invasion in a 3D spheroid model of bladder cancer
Jin‐Nyoung Ho, Jessie S. Jeon, Daniel Kim, et al.
Oncology Reports (2023) Vol. 49, Iss. 6
Closed Access | Times Cited: 3
CUDC-907, a dual PI3K/histone deacetylase inhibitor, increases meta-iodobenzylguanidine uptake (123/131I-mIBG) in vitro and in vivo: a promising candidate for advancing theranostics in neuroendocrine tumors
Joana Grand-Guillaume, Rosalba Mansi, Raghuvir H. Gaonkar, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Developing therapeutic approaches for chronic myeloid leukemia: a review
Veerandra Kumar, Jyotirmayee, Malkhey Verma
Molecular and Cellular Biochemistry (2022) Vol. 478, Iss. 5, pp. 1013-1029
Closed Access | Times Cited: 4
HDAC inhibitor SB939 potentiates TRAIL-induced apoptosis in colorectal cancer cells
Min Shin, Seung Young Seo, Se Lim Kim, et al.
Cellular and Molecular Biology (2023) Vol. 69, Iss. 5, pp. 12-18
Open Access | Times Cited: 2
Clinical benefits of deep inspiration breath-hold in postoperative radiotherapy for right-sided breast cancer: a meta-analysis
LI Zhuo-cheng, Chenxi Jian, Yuanyuan Li, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access
Co-encapsulation of PI3-Kδ/HDAC6 dual inhibitor and Navitoclax in Quatramer™ nanoparticles for synergistic effect in ER+ breast cancer
Sachchidanand Tiwari, Harshdeep Kaur, Mohd Anees, et al.
International Journal of Pharmaceutics (2022) Vol. 628, pp. 122343-122343
Closed Access | Times Cited: 2
Research Progress on Anti-Breast Cancer Mechanism of Main Components in Glycyrrhiza uralensis
猛 王
Advances in Clinical Medicine (2023) Vol. 13, Iss. 05, pp. 7471-7476
Closed Access
TRAIL mediated signaling in different cancers: cancer in the "Crosshairs"
Ammad Ahmad Farooqı, Humaira Naureen, Seher Yılmaz, et al.
Cellular and Molecular Biology (2020) Vol. 66, Iss. 8, pp. 1-8
Open Access
[Effect of DR5-mediated docetaxel-loaded lipid microbubble combined with ultrasoundtargeted microbubble destruction on HepG2 cell proliferation and apoptosis].
Jian Yang, Yong Zeng, Xiaoling Wu, et al.
PubMed (2021) Vol. 41, Iss. 8, pp. 1220-1225
Closed Access
Page 1

Scroll to top